PL326490A1 - Treatment of traumatic brain injuries - Google Patents

Treatment of traumatic brain injuries

Info

Publication number
PL326490A1
PL326490A1 PL96326490A PL32649096A PL326490A1 PL 326490 A1 PL326490 A1 PL 326490A1 PL 96326490 A PL96326490 A PL 96326490A PL 32649096 A PL32649096 A PL 32649096A PL 326490 A1 PL326490 A1 PL 326490A1
Authority
PL
Poland
Prior art keywords
treatment
traumatic brain
brain injuries
injuries
traumatic
Prior art date
Application number
PL96326490A
Other languages
English (en)
Inventor
Brian R Pike
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of PL326490A1 publication Critical patent/PL326490A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL96326490A 1995-11-06 1996-11-05 Treatment of traumatic brain injuries PL326490A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK123295 1995-11-06
PCT/DK1996/000458 WO1997017074A1 (en) 1995-11-06 1996-11-05 Treatment of traumatic brain injury

Publications (1)

Publication Number Publication Date
PL326490A1 true PL326490A1 (en) 1998-09-28

Family

ID=8102484

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96326490A PL326490A1 (en) 1995-11-06 1996-11-05 Treatment of traumatic brain injuries

Country Status (18)

Country Link
EP (1) EP0866706A1 (bg)
JP (1) JPH11514654A (bg)
KR (1) KR19990067353A (bg)
AU (1) AU706594B2 (bg)
BG (1) BG63150B1 (bg)
BR (1) BR9611396A (bg)
CA (1) CA2234824A1 (bg)
CZ (1) CZ287441B6 (bg)
EA (1) EA000531B1 (bg)
HU (1) HUP9901051A2 (bg)
IS (1) IS4726A (bg)
NO (1) NO982036L (bg)
NZ (1) NZ321546A (bg)
PL (1) PL326490A1 (bg)
SK (1) SK58198A3 (bg)
TR (1) TR199800801T2 (bg)
WO (1) WO1997017074A1 (bg)
ZA (1) ZA969320B (bg)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR013096A1 (es) * 1997-07-01 2000-12-13 Lundbeck & Co As H Sal de adicion de acido maleico de 5-(2-etil-2-h-tetrazol-5-il)-1-metil- 1,2,3,6-tetrahidropiridina, composicion farmaceutica que la contiene, su usoen terapia y metodo de preparacion de la misma.
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2275095A3 (en) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス,インコーポレイティド Pde阻害による神経新生の調節
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
US5328925A (en) * 1989-02-22 1994-07-12 Novo Nordisk A/S Piperidine compounds and their use
IE922270A1 (en) * 1991-07-26 1993-01-27 Akzo Nv Pyrazole derivatives
US5330994A (en) * 1992-03-24 1994-07-19 Warner-Lambert Company Tetrahydropyridine isoxazoline derivatives

Also Published As

Publication number Publication date
BG102480A (bg) 1999-01-29
EP0866706A1 (en) 1998-09-30
BR9611396A (pt) 1999-07-13
AU7490096A (en) 1997-05-29
CA2234824A1 (en) 1997-05-15
EA000531B1 (ru) 1999-10-28
EA199800434A1 (ru) 1998-10-29
NO982036D0 (no) 1998-05-05
JPH11514654A (ja) 1999-12-14
CZ138998A3 (cs) 1998-10-14
AU706594B2 (en) 1999-06-17
IS4726A (is) 1998-04-27
NZ321546A (en) 2000-12-22
MX9803432A (es) 1998-09-30
TR199800801T2 (xx) 1998-08-21
NO982036L (no) 1998-06-25
SK58198A3 (en) 1998-10-07
WO1997017074A1 (en) 1997-05-15
CZ287441B6 (en) 2000-11-15
KR19990067353A (ko) 1999-08-16
ZA969320B (en) 1997-05-30
BG63150B1 (bg) 2001-05-31
HUP9901051A2 (hu) 2000-03-28

Similar Documents

Publication Publication Date Title
AU1436595A (en) Method of treatment of traumatic brain injury
ZA96740B (en) Skin treatment composition
IL119747A0 (en) Treatment of vegetables
ZA969520B (en) Use of epinastine for the treatment of pain
GB9500247D0 (en) Treatment of poultry
EP0795035A4 (en) SKIN TREATMENT
PL326490A1 (en) Treatment of traumatic brain injuries
IL131347A0 (en) Treatment of skin disorders
GB2303303B (en) Medical treatment
GB9419048D0 (en) Treatment of muscular disorders
GB9521725D0 (en) Medical treatment
GB9510162D0 (en) Compositions for the treatment of skin conditions
EP0828507A4 (en) METHOD FOR TREATING PAIN
EP0782631A4 (en) PLASMODIUM PARASITE TREATMENT
GB9507825D0 (en) Method of treatment
GB9526264D0 (en) Medical treatment
GB9400600D0 (en) Treatment of motion seckness
GB9216360D0 (en) Treatment of blood
AU4128896A (en) Use of amino-isoxazolidone compounds for treatment of memory impairment following traumatic brain injury
GB9520494D0 (en) Treatment of medical conditions
GB9520496D0 (en) Treatment of medical conditions
GB9520495D0 (en) Treatment of medical conditions
GB9502742D0 (en) Treatment of hrt-associated breast pain
GB9503200D0 (en) Methods of treatment
GB9518723D0 (en) Treatment of coccidiosis